Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Veer Sharma

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO was subscribed over 70 times by the end of the 3-day bidding period on Wednesday for its Rs 939 crore issue. The over-subscription was led by Qualified Institutional Buyers, who bid over 180 times their allotted portion.

The point-of-care molecular diagnostics company is also commanding a 17.10% grey market premium (GMP), up from 15% earlier, indicating expectations of a potentially strong listing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.